Current Edition


First-of-its-kind clinical trial will use reprogrammed adult stem cells to treat Parkinson’s

Researchers in Japan today announced the launch of a clinical trial to treat Parkinson’s disease with neurological material derived from induced pluripotent stem (iPS) cells, …

Continue Reading →

Stem cell symposium to highlight clinical trials, safety and regulation

Twenty years ago this fall, a team of scientists led by James Thomson at the University of Wisconsin–Madison published the first paper describing successful derivation …

Continue Reading →